Key facts
- Notable investors include Jointown Pharmaceutical Group.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Thyssen Pharmaceuticals
- ·The full record, as it builds
Funding rounds
No funding rounds for Thyssen Pharmaceuticals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Thyssen Pharmaceuticals
Manufacturer of traditional Chinese medicine products designed to integrate cultivation, processing, and health product development. The company offers advanced stir-frying techniques, automated processing equipment, and quality-controlled herbal production, enabling TCM distributors and healthcare providers to access safe, standardised, and medicinal products.
- Sector
- Healthcare
- HQ
- Chongqing, China
- Founded
- 2005
- Employees
- 175
- Website
- taisunbio.cn/
- Ownership
- Privately Held (backing)
Thyssen Pharmaceuticals doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Thyssen Pharmaceuticals shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Thyssen Pharmaceuticals in its N-PORT filings yet. We sweep new filings monthly.